Innospec (IOSP) Stock Price, News & Analysis

Company Overview

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels. This segment's products are used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, construction, mining, and other industrial markets. The company's Oilfield Services segment develops and markets chemical solutions for drilling, completion, fracturing, stimulation, and completion operations; and products for oil and gas production. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

Key Stats

• Today's Range: $85.07 to $86.44
• 50-Day Range: $83.39 to $111.80
• 52-Week Range: $80.32 to $133.71
• Volume: 145,646 shs
• Average Volume: 147,413 shs
• Market Capitalization: $2.16 billion
• P/E Ratio: 60.51
• Dividend Yield: 1.84%
• Price Target: N/A
• Consensus Rating: N/A

Innospec Stock Analysis - MarketRank™

Innospec scored higher than 68% of companies evaluated by MarketBeat, and ranked 120th out of 186 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Innospec.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 12.62%

Earnings Growth

Earnings for Innospec are expected to grow by 12.62% in the coming year, from $6.18 to $6.96 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Innospec is 60.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.40.

Price to Earnings Ratio vs. Sector

The P/E ratio of Innospec is 60.51, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 75.92.

Price to Book Value per Share Ratio

Innospec has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.55% of the float of Innospec has been sold short.

Short Interest Ratio / Days to Cover

Innospec has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Innospec has recently decreased by 16.52%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Innospec pays a meaningful dividend of 1.81%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Innospec does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Innospec is 111.27%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Innospec will have a dividend payout ratio of 22.70% next year. This indicates that Innospec will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.55% of the float of Innospec has been sold short.

Short Interest Ratio / Days to Cover

Innospec has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Innospec has recently decreased by 16.52%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.20

News Sentiment

Innospec has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Innospec this week, compared to 4 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Innospec insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $794,853.00 in company stock.

Percentage Held by Insiders

Only 1.31% of the stock of Innospec is held by insiders.

Percentage Held by Institutions

96.64% of the stock of Innospec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

IOSP Stock Analysis - Frequently Asked Questions

How have IOSP shares performed this year?

Innospec's stock was trading at $110.06 on January 1st, 2025. Since then, IOSP stock has decreased by 21.9% and is now trading at $85.92.
View the best growth stocks for 2025 here.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its earnings results on Tuesday, February, 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.36 by $0.05. The specialty chemicals company earned $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a trailing twelve-month return on equity of 12.27% and a net margin of 1.93%.
Read the conference call transcript.

Is Innospec doing a stock buyback?

Innospec's board approved a share repurchase plan on Monday, March 10th 2025, which authorizes the company to buy back $50,000,000 in shares, according to EventVestor. This means that the company could buy up to 2% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its stock is undervalued.

Who are Innospec's major shareholders?

Innospec's top institutional shareholders include Rhumbline Advisers (0.31%), GAMMA Investing LLC (0.13%), Vest Financial LLC (0.08%) and Yousif Capital Management LLC (0.04%). Insiders that own company stock include Patrick Williams, Philip John Boon, Ian Cleminson, David B Jones, Milton C Blackmore, Corbin Barnes, Larry Padfield, Leslie J Parrette, Hardy Louis Griffin III and Claudia Poccia.
View institutional ownership trends.

How do I buy shares of Innospec?

Shares of IOSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Innospec investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Visa (V) and Home Depot (HD).

Company Calendar

• Last Earnings: 2/18/2025
• Today: 4/20/2025
• Next Earnings (Estimated): 5/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: Chemicals & allied products
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:IOSP
• CIK: 1054905
• Web: www.innospecinc.com
• Phone: (303) 792-5554
• Fax: 303-792-5668
• Employees: 2,100
• Year Founded: 1938

Profitability

• EPS (Most Recent Fiscal Year): $1.42
• Trailing P/E Ratio: 60.51
• Forward P/E Ratio: 13.90
• P/E Growth: N/A
• Net Income: $139.10 million
• Net Margins: 1.93%
• Pretax Margin: 2.23%
• Return on Equity: 12.27%
• Return on Assets: 8.54%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.58
• Quick Ratio: 1.73

Sales & Book Value

• Annual Sales: $1.85 billion
• Price / Sales: 1.17
• Cash Flow: $6.41 per share
• Price / Cash Flow: 13.41
• Book Value: $48.72 per share
• Price / Book: 1.76

Miscellaneous

• Outstanding Shares: 25,120,000
• Free Float: 24,563,000
• Market Cap: $2.16 billion
• Optionable: Optionable
• Beta: 1.03